Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
11 2021
Historique:
received: 27 08 2020
revised: 17 03 2021
accepted: 28 03 2021
pubmed: 14 4 2021
medline: 4 11 2021
entrez: 13 4 2021
Statut: ppublish

Résumé

There are concerns that policies aimed to prevent opioid misuse may unintentionally reduce access to opioids for patients at end-of-life. We assessed trends in opioid prescribing among patients on discharge from the hospital to hospice care. This was a retrospective cohort study among adult (age ≥18 years) patients discharged from a 544-576 bed, academic medical center to hospice care between January 1, 2010 to December 31, 2018. Study data were collected from a repository of patients' electronic health record data. Our primary outcome was the frequency of opioid prescribing on discharge to hospice care. Our primary exposure was the calendar year of discharge. We also investigated non-opioid analgesic prescribing and stratified opioid prescribing trends by patient characteristics (e.g., demographics, cancer diagnosis, and location of hospice care). Among 2,648 discharges to hospice care, mean (standard deviation) age was 65.8 (16.0) years, 46.3% were female, and 58.7% had a cancer diagnosis. Opioid prescribing on discharge to hospice care decreased significantly from 91.2% (95% confidence interval (CI) = 87.1%-94.1%) in 2010 to 79.3% (95% CI = 74.3%-83.5%) in 2018 adjusting for age, sex, cancer diagnosis, and location of hospice care. Prescribing of non-opioid analgesic medications increased over the same time period. We observed a statistically significant decreasing trend in opioid prescribing on discharge to hospice care. Further research should aim to confirm these findings and to identify opportunities to ensure optimal pain management among patients transitioning to hospice care.

Identifiants

pubmed: 33848567
pii: S0885-3924(21)00279-7
doi: 10.1016/j.jpainsymman.2021.03.025
pmc: PMC8502178
mid: NIHMS1695229
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1026-1033

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002369
Pays : United States

Informations de copyright

Copyright © 2021 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Références

Antimicrob Agents Chemother. 2014 Sep;58(9):5473-7
pubmed: 25001299
Ann Intern Med. 2010 Nov 2;153(9):563-9
pubmed: 21041575
Am Fam Physician. 2014 Jul 1;90(1):26-32
pubmed: 25077499
Med Care. 2016 Oct;54(10):901-6
pubmed: 27623005
J Gerontol B Psychol Sci Soc Sci. 2009 Nov;64(6):799-807
pubmed: 19465748
Support Care Cancer. 2005 Nov;13(11):888-94
pubmed: 15818486
Am J Hosp Palliat Care. 2020 Jul;37(7):507-513
pubmed: 31763926
Am J Hosp Palliat Care. 2014 Mar;31(2):126-31
pubmed: 23408370
Cochrane Database Syst Rev. 2013 Aug 29;(8):CD006146
pubmed: 23986501
J Palliat Med. 2013 Mar;16(3):237-42
pubmed: 23289944
Ann Oncol. 2009 Apr;20(4):729-35
pubmed: 19164455
J Palliat Med. 2017 Aug;20(8):850-856
pubmed: 28333571
Drug Alcohol Depend. 2019 Nov 1;204:107563
pubmed: 31585357
J Pain Symptom Manage. 2016 Jun;51(6):1070-1090.e9
pubmed: 27112310
N Engl J Med. 2019 Jun 13;380(24):2285-2287
pubmed: 31018066
Cochrane Database Syst Rev. 2017 Jul 06;7:CD012592
pubmed: 28683172
Lancet Oncol. 2012 Feb;13(2):e58-68
pubmed: 22300860
J Pain Symptom Manage. 2015 Nov;50(5):630-41
pubmed: 26159294
Med Care. 2020 Dec;58(12):1069-1074
pubmed: 32925461
Lancet. 2001 Apr 28;357(9265):1311-5
pubmed: 11343734
J Pain Palliat Care Pharmacother. 2019 Mar - Jun;33(1-2):54-58
pubmed: 31592735
J Pain Symptom Manage. 2002 Jul;24(1 Suppl):S38-47
pubmed: 12204486
J Am Geriatr Soc. 2019 Jun;67(6):1258-1262
pubmed: 30854629
J Palliat Med. 2020 Jul;23(7):900-906
pubmed: 31895623
Pain Med. 2011 Jun;12(6):880-9
pubmed: 21539700
J Palliat Med. 2017 Nov;20(11):1225-1230
pubmed: 28581881
J Pain Symptom Manage. 2004 Feb;27(2):114-24
pubmed: 15157035
J Hosp Palliat Nurs. 2019 Oct;21(5):365-372
pubmed: 30920493
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD005180
pubmed: 15654708

Auteurs

Jon P Furuno (JP)

Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA. Electronic address: furuno@ohsu.edu.

Brie N Noble (BN)

Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA.

Erik K Fromme (EK)

Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, Massachusetts, USA; Ariadne Labs at Brigham and Women's Hospital and the Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

Daniel M Hartung (DM)

Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, Oregon, USA.

Jennifer Tjia (J)

Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Mary Lynn (M)

Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

Joan M Teno (JM)

Division of General Internal Medicine & Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH